Zhongnan Medical Journal Press

Home Results

A total of 12 result was found. Results that relate to Chemotherapy

Chemotherapy for 3 cases of shock caused by macrophage activation syndrome secondary to adult-onset Still’s disease and an associated literature review

Published on New Medicine 2021,31(1):390-394.
3663 times 2335 times

Wen-Yan XIAO Tian-Feng HUA Yao ZHENG Hui LI Min YANG

Chemotherapy Adult-onset Still’s disease Macrophage activation syndrome Shock
Details
Pathological features of HER-2 hypoexpression breast cancer and its effect on neoad-juvant chemotherapy

Published on Journal of Mathematical Medicine 2023,36(4):282-287.
1510 times 523 times

Jing WANG Nan WANG Xian-Hua QIU

Breast cancer HER-2 Clinicopathological features Neoadjuvant chemotherapy
Details
Analysis of five-step nutrition combined with CAPEOX chemotherapy in patients with postoperative adjuvant chemotherapy for colorectal cancer

Published on Journal of Mathematical Medicine 2023,36(5):352-357.
1354 times 385 times

Zhen FENG Fang ZHOU Han HU Guo-Wu QIAN

CAPEOX Chemotherapy Five-step nutrition Colorectal cancer Adjuvant chem-otherapy Nutritional status
Details
Effect of platinum-containing regimen combined with chemotherapy on the survival of elderly patients with advanced non-small cell lung cancer

Published on Journal of Mathematical Medicine 2023,36(12):899-905.
1202 times 578 times

Xue-Xing WANG Yuan HE Jie CHU Yu-Feng WANG

Non-small cell lung cancer Retrospective cohort study Chemotherapy The elderly Survival analysis
Details
Efficacy and safety of sindilizumab combined with intensity modulated radiotherapy and chemotherapy in patients with advanced cervical cancer

Published on Frontiers in Pharmaceutical Sciences 2023,36(12):456-464.
996 times 384 times

Jiang-Yue TANG Lin WANG Jing ZHANG Rong REN Ling CHEN

Advanced cervical cancer Sindilimab Intensity modulated radiotherapy and chemotherapy Clinical efficacy Security
Details
Clinical efficacy and safety evaluation of probiotic-assisted chemotherapy in patients with advanced colorectal cancer

Published on Frontiers in Pharmaceutical Sciences 2024,27(2):295-301.
903 times 467 times

YE Fan LI Zhuo HUANG Xing XIAO Zhigang

Advanced colorectal cancer Chemotherapy Probiotics Clinical efficacy Safety
Details
PD-1 inhibitor combined with chemotherapy in the treatment of metastatic nasopharyngeal carcinoma: a case report

Published on Journal of Mathematical Medicine 2024,37(5):392-397.
1283 times 581 times

CHENG Yanshuang WANG Juan JIN Jieying WU Qiuji ZHONG Yahua

Nasopharyngeal carcinoma PD-1 inhibitor Immunotherapy Chemotherapy
Details
Changes of coagulation function before and after neoadjuvant chemotherapy in patients with ovarian cancer and their clinical significance

Published on Frontiers in Pharmaceutical Sciences 2024,27(5):802-809.
976 times 380 times

SHI Wan YANG Yaxing CHEN Chu WANG Miao WANG Yongfeng WEI Xin LEI Fang

Ovarian cancer Neoadjuvant chemotherapy Coagulation function Platelets count Effect
Details
Progress of clinical research on immunotherapy and antibody-drug conjugates for the treatment of triple-negative breast cancer

Published on Frontiers in Pharmaceutical Sciences 2024,27(5):901-908.
1104 times 366 times

YANG Dan WANG Jinxiu MAO Dahua

Triple-negative breast cancer Immunotherapy Antibody-drug conjugates Clinical trials Immune checkpoint inhibitors Chemotherapy
Details
Risk assessment and prediction model for capecitabine-induced chemotherapy-related adverse reactions in colorectal cancer patients

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):992-998.
974 times 238 times

CHEN Shaobo WU Xutao QIU Wenhui HU Tingting

Colorectal cancer Capecitabine Chemotherapy-induced adverse efects Risk prediction model
Details
Analysis of the prognostic value of NLR in the treatment of PD-1 inhibitors in patients with HER2-negative advanced gastric cancer

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1063-1071.
1008 times 231 times

DOU Yalin CHENG Weili SUN Mingqi WU Shuanghong YANG Tingting LI Dapeng

Advanced gastric cancer Immunotherapy Neutrophils/lymphocytes Prognosis Chemotherapy human Epdermal growth factor receptor
Details
Cost-utility analysis of pembrolizumab combined with chemotherapy for advanced malignant pleural mesothelioma

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1107-1114.
325 times 60 times

HU Yunjia ZOU Keqing HOU Yanhong

Pembrolizumab Chemotherapy Advanced malignant pleural mesothelioma Partitioned survival model Cost-utility analysis Pharmacoeconomic evaluation
Details